BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 10116468)

  • 1. Dominos that wouldn't fall: understanding the failure of competitive reform.
    Higgins W
    J Am Health Policy; 1991; 1(3):29-35. PubMed ID: 10116468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myths of competitive reform.
    Higgins W
    Health Care Manage Rev; 1991; 16(1):65-72. PubMed ID: 2004913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. President Bush's comprehensive health reform program.
    Sullivan LW
    J Am Health Policy; 1992; 2(2):15-8. PubMed ID: 10117907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health policy report. Health care and American business.
    Iglehart JK
    N Engl J Med; 1982 Jan; 306(2):120-4. PubMed ID: 7053486
    [No Abstract]   [Full Text] [Related]  

  • 5. Why wait for Hillary?
    Solomon J; Thomas R; Hager M; Meyer M; Nayyar S
    Newsweek; 1993 Jun; 121(26):38-40. PubMed ID: 10127707
    [No Abstract]   [Full Text] [Related]  

  • 6. Integrated health care plans cut costs without sacrificing care.
    Polakoff PL
    Occup Health Saf; 1986 Feb; 55(2):58-9. PubMed ID: 3960455
    [No Abstract]   [Full Text] [Related]  

  • 7. Market dynamics 1995.
    Cochrane JD
    Integr Healthc Rep; 1996 Jan; ():1-8. PubMed ID: 10154836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competition in hospital and health insurance markets: a review and research agenda.
    Morrisey MA
    Health Serv Res; 2001 Apr; 36(1 Pt 2):191-221. PubMed ID: 11327174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competition and market forces: an answer to cost containment in health care?
    Enthoven AC
    Acta Hosp; 1982; 22(3):207-34. PubMed ID: 10258414
    [No Abstract]   [Full Text] [Related]  

  • 10. The new health policy: promises and pitfalls.
    Marmor TR
    Health Policy Q; 1982; 2(2):70-8. PubMed ID: 10259097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Managed care in the 1990s.
    Hunt M
    Health Care Strateg Manage; 1985 Dec; 3(12):20-4. PubMed ID: 10274991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong medicine for health bills.
    Gannes S
    Fortune; 1987 Apr; 115(8):70-4. PubMed ID: 10281294
    [No Abstract]   [Full Text] [Related]  

  • 13. Competition versus regulation: constraining hospital discharge costs.
    Weil TP
    J Health Care Finance; 1996; 22(3):62-74. PubMed ID: 8777710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care spending controls: a menu of approaches.
    Ebeler JC; Ferman JH
    J Am Health Policy; 1992; 2(3):33-7. PubMed ID: 10118225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The competitive effects of HMOs: a review of the evidence.
    Frank RG; Welch WP
    Inquiry; 1985; 22(2):148-61. PubMed ID: 3159671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preferred provider organizations: antitrust aspects and implications for the hospital industry.
    Batavia AI
    Am J Law Med; 1984; 10(2):169-88. PubMed ID: 6528879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Market responses to HMOs: price competition or rivalry?
    McLaughlin CG
    Inquiry; 1988; 25(2):207-18. PubMed ID: 2968311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinton's master plan. Final decisions on health reform: how much it will cost and who pays.
    Dentzer S
    US News World Rep; 1993 May; 114(20):22-4, 26, 28. PubMed ID: 10126358
    [No Abstract]   [Full Text] [Related]  

  • 19. In due time.
    Filerman GL
    Health Manage Q; 1992; 14(4):7-11. PubMed ID: 10123080
    [No Abstract]   [Full Text] [Related]  

  • 20. What health care cost crisis?
    Levin JE
    Benefits Q; 1991; 7(3):75-9. PubMed ID: 10117175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.